Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMB-001 for Smoking Cessation
NCT04933916Phase 2Terminated
- Sponsor
- Embera NeuroTherapeutics
- Start
- Jun 2021
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metyrapone + oxazepam in Tobacco Use Disorder (TUD), sponsored by Embera NeuroTherapeutics. Started Jun 2021; status: terminated.
02
Drugs
metyrapone + oxazepam
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT04933916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04933916.